The bill, a slimmed-down version of President Joe Biden’s Build Back Better package, also allows Medicare to negotiate select prescription drug prices beginning in 2026 and caps Medicare Part D out-of-pocket costs in 2025.

The growth of high-deductible health plans led to people with employer-sponsored coverage paying for a larger share, on average, of their health care costs between 2013 and 2019, according to a new analysis by the Employee Benefit Research Institute.

The CMS is asking for public feedback on how to make the Medicare Advantage program more affordable, sustainable and equitable for enrollees, while driving better health outcomes.

Have you had COVID a second time? Or a third? If so, you are in good company. New data from California’s public health department show that in the first three weeks of July there were more than 50,000 documented reinfections, accounting for 1 in 7 new COVID cases through the middle of the month. And, ...

Executives from some of the country’s largest for-profit health systems say it’s likely their organizations will be able to pass rising cost pressures along to commercial insurers during the next round of contract negotiations. Speaking to investors during earnings calls this past week, the hospital chains each reported limited non-COVID volumes, supply chain interruptions and ...

Democrats want to go into their August recess telling their constituents they’re lowering what they pay for medicines — but many of their promised changes won’t be felt for years, and only by a fraction of the nation. Drug-pricing legislation is expected to get a vote in the Senate as soon as this week as ...